New Developments in Lipid Guidelines and PCSK9 Antibodies

New Developments in Lipid Guidelines and PCSK9 Antibodies is organized by Pri-Med and will be held during May 25, 2016 - May 25, 2019. This CME Conference has been approved for a maximum of 1.00 Credits.

Overview :

Learn the best practices to screen for and manage hypercholesterolemia and other lipid disorders in your clinic. Get updates on the latest drugs available to combat these conditions, and become familiar with the current practice guidelines for statin use in patients.

Learning Objectives :

• Review current ACC/AHA cholesterol guidelines for dyslipidemia
• Present consensus document recommendations from the NLA and the ACC
• Discuss physiology of PCSK9, role of antibody therapy and updated outcomes data from clinical trials

Additional details will be posted as soon as they are available.